Form 4: AtriCure Director Deborah H. Telman Reports Stock Award and Disposal

Director Deborah H. Telman reports acquisition of 7,788 shares of AtriCure, Inc. through a restricted stock award and disposal of 16,783 shares.

Summary

• On May 13, 2024, Deborah H. Telman, a director of AtriCure, Inc., acquired 7,788 shares of common stock through a restricted stock award under the company's 2023 Stock Incentive Plan.
• These shares will vest on the one-year anniversary of the grant date.
• On the same day, Telman disposed of 16,783 shares.
• Following these transactions, Telman beneficially owns 16,783 shares of AtriCure, Inc.

Sentiment

Score: 5

Explanation: Neutral sentiment as the document primarily reports transactions without providing explicit positive or negative outlook.

Positives

• The acquisition of shares through a restricted stock award aligns the director's interests with the company's long-term performance.

Negatives

• The disposal of 16,783 shares by the director could be interpreted negatively by investors, although the reason for disposal is not disclosed.

Risks

• The disposal of a significant number of shares by a director could create uncertainty among investors regarding the company's prospects.

Industry Context

Form 4 filings are standard disclosures required by the SEC to provide transparency regarding the transactions of company insiders. These filings are closely monitored by investors to gauge sentiment and potential future performance.

Stakeholder Impact

• The stock transactions by a company director may influence investor sentiment and potentially affect the stock price.

Key Dates